Protection of oral hydrogen water as an antioxidant on pulmonary hypertension.
Bin He, Yufeng Zhang, Bo Kang, Jian Xiao, Bing Xie, Zhinong Wang · Molecular biology reports · 2013
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In rats, semi-quantitative scoring of the lung tissue in different groups showed that the lung tissue injury score of MCT group was significantly higher than that of SHAM group. The lung tissue injury score of MCT+Oral-H₂ and MCT+Inj-H₂ groups was significantly lower than that of MCT group (* P < 0.05 compared with SHAM group; ※ P < 0.05 compared with MCT group). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in rats. Semi-quantitative scoring of the lung tissue in different groups showed that the lung tissue injury score of MCT group was significantly higher than that of SHAM group. The lung tissue injury score of MCT+Oral-H₂ and MCT+Inj-H₂ groups was significantly lower than that of MCT group (* P < 0.05 compared with SHAM group; ※ P < 0.05 compared with MCT group).
What the Researchers Studied
The researchers studied rats. The study used a preclinical animal experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Animals in SHAM group were administered with Oral-H₂ only, and the other groups were administered with intraperitoneal injection of MCT (80 mg/kg). Those in MCT+Oral-H₂ group or MCT+Inj-H₂ group were administered with Oral-H₂ or Inj-H₂ respectively. Semi-quantitative scoring of the lung tissue in different groups showed that the lung tissue injury score of MCT group was significantly higher than that of SHAM group. The lung tissue injury score of MCT+Oral-H₂ and MCT+Inj-H₂ groups was significantly lower than that of MCT group (* P < 0.05 compared with SHAM group; ※ P < 0.05 compared with MCT group). The authors concluded that these indexes were decreased significantly in both MCT+Oral-H₂ group and MCT+Inj-H₂ group, which indicate Oral-H₂ and Inj-H₂ have similar effects of preventing the development of PH and mitigating RV hypertrophy. The protective effect of hydrogen is associated with its antioxidative ability and action of reducing pulmonary inflammatory response. hydrogen could reduce inflammatory response and 3-nt and ICAM-1 levels in the course of PH formation, suggesting that the therapeutic effect of hydrogen in the treatment of PH is closely correlated with antioxidative stress.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was rats. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.